These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 1397240)

  • 1. Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004.
    Tobinai K; Takeyama K; Arima F; Aikawa K; Kobayashi T; Hanada S; Kasai M; Ogura M; Sueoka E; Mukai K; Tajima K; Fukuda H; Shirakawa S; Hotta T; Masanori S;
    Cancer Sci; 2007 Sep; 98(9):1350-7. PubMed ID: 17640299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
    Kim TK; Xu ML; Podoltsev NA; Prebet T; Barbarotta L; Amin K; Kasberg S; Roche K; Stahl M; Gore SD; Zeidan AM
    Ann Hematol; 2016 Oct; 95(11):1895-8. PubMed ID: 27468851
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses.
    Ness KK; Hudson MM; Pui CH; Green DM; Krull KR; Huang TT; Robison LL; Morris EB
    Cancer; 2012 Feb; 118(3):828-38. PubMed ID: 21766297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adult acute lymphoblastic leukaemia.
    Jacobs P; Wood L; Novitzky N
    Haematol Blood Transfus; 1990; 33():428-31. PubMed ID: 2323650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
    Larson RA; Dodge RK; Burns CP; Lee EJ; Stone RM; Schulman P; Duggan D; Davey FR; Sobol RE; Frankel SR
    Blood; 1995 Apr; 85(8):2025-37. PubMed ID: 7718875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Colović M; Bogdanović A; Janković G; Kraguljac N; Suvajdzić N
    Chemotherapy; 2003 Jun; 49(3):138-45. PubMed ID: 12815207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P; Wood L
    Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
    Lee EJ; Petroni GR; Schiffer CA; Freter CE; Johnson JL; Barcos M; Frizzera G; Bloomfield CD; Peterson BA
    J Clin Oncol; 2001 Oct; 19(20):4014-22. PubMed ID: 11600602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
    Weiss M
    Hematol Oncol Clin North Am; 2001 Feb; 15(1):1-7, v. PubMed ID: 11253603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hyper-CVAD regimen in adult acute lymphocytic leukemia.
    Garcia-Manero G; Kantarjian HM
    Hematol Oncol Clin North Am; 2000 Dec; 14(6):1381-96, x-xi. PubMed ID: 11147229
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.